Selective mannosidase inhibitors as cancer therapeutics

CARB 60

Jun Guo, junguo@uga.edu1, Jinkeng Asong1, and Geert-Jan Boons2. (1) Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, (2) Department of Chemistry, Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Rd, Athens, GA 30602-4712
Remarkable changes in cell-surface carbohydrates occur with tumor progression, which appears to be intimately associated with the dreaded state if metastasis. Thus, glycosidase inhibitors that can interfere in the biosynthesis of oligosaccharides are regarded as attractive leads for drug discovery for a wide range of diseases. However, it has been difficult to develop safe and selective glycosidase inhibitors. We report herein our approaches for the design and synthesis of selective mannosidase inhibitors based on feedback inhibition and specific protease hydrolysis.
 

General Posters
6:00 PM-8:00 PM, Tuesday, March 27, 2007 Hyatt Regency Chicago -- Riverside Center, Poster

Division of Carbohydrate Chemistry

The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007